R, C., RP, D., & MW, S. (2024). Reevaluating Piperacillin-Tazobactam Mortality-Reply. JAMA internal medicine, 184(10), 1269. https://doi.org/10.1001/jamainternmed.2024.4120
Chicago Style (17th ed.) CitationR, Chanderraj, Dickson RP, and Sjoding MW. "Reevaluating Piperacillin-Tazobactam Mortality-Reply." JAMA Internal Medicine 184, no. 10 (2024): 1269. https://doi.org/10.1001/jamainternmed.2024.4120.
MLA (9th ed.) CitationR, Chanderraj, et al. "Reevaluating Piperacillin-Tazobactam Mortality-Reply." JAMA Internal Medicine, vol. 184, no. 10, 2024, p. 1269, https://doi.org/10.1001/jamainternmed.2024.4120.
Warning: These citations may not always be 100% accurate.